Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Have been shopping…. $1bn for preclinical. Thanks to Rah for sharing on twatter.
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-buy-radiology-specialist-mariana-oncology-1-billion-2024-05-02/
Lolz a plenty if one of the options that’s back on the table is agreeing to a takeover. I’d suggest a bit more than $1bn given platform technologies and being in the clinic. You could imagine Alan digging his heels in and you could imagine Chris thinking a quick payday could work out nicely.
I don't think Apicel is irrelevant to Abakta, it still holds a value. If the value can be unlocked then it's a winner. There could be a bigger appetite for investing over there and we can gain from it. If not, nothing ventured....
I imagine it’s an option. Apicel aren’t having around though, it be fascinating to see how it gets on in the clinic. An IPO could serve the same purpose, a chance to retain some ownership and get some capital for Tx coffers.
He didn't like the Paul Hill interview as Paul went off script and asked him about the commercial strategy - for clout obviously. Not only did Alan have a face like thunder he stumbled and thoroughly embarrassed himself - not a good sign for a CEO. Whatever, he's gone.
I’ve been critical for years, thank you. No issues with the M&A, it’s the original Dx that’s drained the cash - Alan’s pet project. It’s no shock that Tx needs cash on an ongoing basis, if we could have raised at a 10% discount, why didn’t we? I blame Alan, he had PI cash on the table and chose to grease city boys to get what he views as a prestige name on the register. Unless Bella’s theories are right, it’s looking like he was led by his ego. He was delighted by courting Sequoia Carpets, it meant nowt to the business. If they were strategic partners and willing to provide on going cheap finance, kudos to him. They weren’t, we’re just a punt for them. If it’s sold for £1bn, it’s a massive failure.
I’d be fascinated by a discussion thread on the general board with all trades posted as they happen.
Otherwise, I imagine some dribbling window lickers with a set of crayons absolutely love the painting by numbers series from the catastrophically failed gambler.
Quality assessment Nano. Think you hit the nail on the head in your final sentence of point 3. Pretty sure Alan felt he knew best and enjoyed his lifestyle generating position. His stubbornness has held the company back. Perhaps there have been clashes and that's why CC was confirming that everything was now on the table. Good luck to her, here's hoping she has a good strategic head on her shoulders.
Rory, I agree that the finances are in a state. They need to get rid of the garbage in Dx, slim it to a profitable position so that it can contribute or be sold to give them the cash runway they need. A fire sale of Dx would also achieve that as 2026 could be the year that they get marketing approval for an indication for ava6k. They're not far off delivering commercially if you think in years rather than months and they're sat on enough to 'probably' see them to 2026. I also agree that the research pipeline that CC is excited about could be seen as a cash drain - unless their preliminary conversations lead to licencing opportunities from this PoC work. I'd prefer that they get ava6k over the line, start making cash and then start expanding their horizons. I'd be delighted for Simon to sign a deal and prove me very wrong.
I'm happy with Dx now we've got it, if (and whilst Tony is doing the sums we can't say for sure) it is cash generative. Tony reckons this will happen in H224. Selling it at a loss would compound the original M&A strategy error. If it's adding to the bottom line, keep it. Hopefully it'll generate enough cash to cover the HCI payments in cash.